02.03.2013 Views

Target Discovery and Validation Reviews and Protocols

Target Discovery and Validation Reviews and Protocols

Target Discovery and Validation Reviews and Protocols

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Keratin Transgenics <strong>and</strong> Knockouts 223<br />

the latter case, HPRT-deficient ES cells are required. Only ES cells that harbor<br />

an HPRT-minigene can grow in hypoxanthine, aminopterin, <strong>and</strong> thymidine<br />

(HAT)-containing selective medium. The major advantage of the HPRT system<br />

is that it allows for negative selection in medium containing 6-thioguanine<br />

(6-TG) (103). In our experience, we have not observed any advantage for the<br />

use of negative selectable marker genes outside the homology arms.<br />

In most cases, selectable marker genes with their own promoters, usually<br />

PGK-1, are used. In rare instances, the phosphoglycerate kinase (PGK)-1 promoter<br />

becomes silenced because it carries a partial pCpG isl<strong>and</strong> <strong>and</strong> may have to<br />

be replaced by other promoters (105). To minimize transcriptional interference<br />

between the gene’s own promoter <strong>and</strong> the minigene promoter, we recommend<br />

placing the selectable marker gene opposite the target gene’s transcriptional orientation.<br />

To minimize potential effects of the selectable marker gene on neighboring<br />

genes, <strong>and</strong> on the phenotype of mice, it is desirable to remove it. This removal<br />

can be done by placing Lox P or FRT recognition sequences at both ends of the<br />

selectable marker cassette. After transient expression of Cre or Flp-recombinase<br />

in ES cells, the marker gene is removed <strong>and</strong> ES cells become sensitive to the<br />

selective agent. This selectivity allows the use of the original targeting vector to<br />

create ES cells homozygous at the targeting locus (106,107). If conditional gene<br />

targeting is planned, it is advisable to use FRT sites to tag the selectable marker<br />

gene (Fig. 4B).<br />

For those IF genes that are transcribed in ES cells, very high gene targeting<br />

frequencies can be achieved using promoterless selectable marker genes that<br />

are placed in the first coding exon, either in frame with the endogenous ATG<br />

codon or by positioning the initiation codon of the marker gene downstream<br />

from the major transcription start site. If insertion of a promoterless marker<br />

gene is required in an exon further 3′ into the gene, an IRES (108) can be incorporated<br />

to enable translation of the marker gene. A slight modification of the<br />

aforementioned design can be used to introduce a promoterless reporter gene<br />

along with the selectable marker to follow the cells carrying the targeted allele.<br />

The enhanced green fluorescent protein- or the more sensitive lacZ-reporter<br />

genes are convenient but do not necessarily provide quantitative readouts<br />

(109,110).<br />

There are several ways to introduce subtle alterations, i.e., point mutations,<br />

into genes. The mutation can be positioned in one of the homology arms of<br />

the targeting vector <strong>and</strong> be cotransferred along with the selectable marker, provided<br />

recombination does not separate the mutation from the selectable marker<br />

(Fig. 4B). The selectable marker gene has to be positioned either in a noncoding<br />

exon or in an intron, from where it can be removed using Flp or Cre-recombinases,<br />

leaving one recombinase recognition site in the genome. In general,<br />

cotransfer of mutations work well, provided the distance between the marker

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!